Pages that link to "Q34093736"
Jump to navigation
Jump to search
The following pages link to Dysregulation of the mevalonate pathway promotes transformation (Q34093736):
Displaying 50 items.
- Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway (Q24302433) (← links)
- Mitochondria, cholesterol and cancer cell metabolism (Q26741708) (← links)
- Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway (Q26771260) (← links)
- A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis (Q26774351) (← links)
- MYC and metabolism on the path to cancer (Q26798086) (← links)
- Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies (Q26823118) (← links)
- Synthetic high-density lipoprotein-like nanoparticles as cancer therapy (Q26825009) (← links)
- The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy (Q26859775) (← links)
- Tumor suppressor p53 and its mutants in cancer metabolism (Q27010683) (← links)
- Statin use and breast cancer survival and risk: a systematic review and meta-analysis (Q28082068) (← links)
- Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility (Q28304661) (← links)
- Retracted: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells (Q28486174) (← links)
- Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis (Q28539314) (← links)
- A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia (Q28820781) (← links)
- Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells (Q33638286) (← links)
- The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway (Q33757009) (← links)
- Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events (Q33865098) (← links)
- Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer (Q33906118) (← links)
- Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells (Q33917134) (← links)
- Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer (Q34017200) (← links)
- Statins and breast cancer prognosis: evidence and opportunities. (Q34206487) (← links)
- The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas (Q34404780) (← links)
- Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells (Q34430735) (← links)
- Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. (Q35103289) (← links)
- Extensive decoupling of metabolic genes in cancer (Q35593094) (← links)
- Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo (Q36021018) (← links)
- Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR (Q36090422) (← links)
- Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells (Q36134002) (← links)
- Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. (Q36172482) (← links)
- p53 regulates the mevalonate pathway in human glioblastoma multiforme. (Q36246455) (← links)
- Synthetic high-density lipoprotein-like nanoparticles for cancer therapy (Q36264073) (← links)
- Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation (Q36277279) (← links)
- Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy (Q36284940) (← links)
- Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake (Q36337964) (← links)
- Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death. (Q36413650) (← links)
- Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers (Q36430122) (← links)
- Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism (Q36503853) (← links)
- Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells (Q36544608) (← links)
- Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway (Q36771848) (← links)
- Candidate cancer-targeting agents identified by expression-profiling arrays (Q36802115) (← links)
- Hypothesis: solid tumours behave as systemic metabolic dictators (Q36942376) (← links)
- Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one (Q36997756) (← links)
- Statin use in primary inflammatory breast cancer: a cohort study. (Q37040602) (← links)
- Synthesis of apolipoprotein B lipoparticles to deliver hydrophobic/amphiphilic materials (Q37098699) (← links)
- A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells. (Q37109747) (← links)
- Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age (Q37163342) (← links)
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development (Q37287417) (← links)
- Molecular pathways: sterols and receptor signaling in cancer (Q37383236) (← links)
- The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level. (Q37396993) (← links)
- Statins and risk of breast cancer recurrence (Q37407449) (← links)